MedPath

Effect of Deksmedetomidine and Remifentanil in Extubation Agitation

Phase 4
Conditions
Agitation
Interventions
Drug: Saline
Drug: deksmedetomidine
Registration Number
NCT02104297
Lead Sponsor
Diskapi Yildirim Beyazit Education and Research Hospital
Brief Summary

To compare the effect of two different agents deksmedetomidine, remifentanil and placebo, agitation and recovery condition, on nasal septum operation.

Detailed Description

Nasal septum operation cause agitation because of nasal package. This research aims determine which agent , deksmedetomidine remifentanil or placebo, is more beneficial to the patient.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Adult patients
Exclusion Criteria
  • patients with any sensitivity each drug

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Saline infusionSalineSaline infused during operation and at the end of surgery agitation scor measured by Riker sedation agitation scale.
Deksmedetomidine infusiondeksmedetomidineTo prevent agitation deksmedetomidine infused during operation and at the end of surgery agitation scor measured by Riker sedation agitation scale.
Remifentanil infusionRemifentanilTo prevent agitation remifentanil infused during operation at the end of surgery agitation scor measured by Riker sedation agitation scale.
Primary Outcome Measures
NameTimeMethod
To asses postoperative agitation score by Riker sedation agitation scalePostoperative first hour
Secondary Outcome Measures
NameTimeMethod
Yo asses postoperative side effects emesis, vomitting or painPostoperative first hour

Trial Locations

Locations (1)

Reyhan Polat

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath